Plant Therapeutics · Clinical Research

HEALING
ROOTED
IN THE
EARTH.

The People's Ecosystem creates plant-derived therapeutic products purpose-built for medical clinical trials — advancing the science of plant medicine for communities who need it most.

Just another WordPress site

"The plants have always known. We are building the science to prove it."

Christine De La Rosa — Founder, The People's Ecosystem
Plant TherapeuticsClinical ResearchSocial EquityBlack-OwnedCommunity-CenteredEvidence-BasedOakland CAPlant TherapeuticsClinical ResearchSocial EquityBlack-OwnedCommunity-CenteredEvidence-BasedOakland CA
$5M+
Capital Raised
10+
Years in Plant Medicine
100%
Black & Brown Leadership
Phase I
Trial Cohort Now Open

From advocacy
to evidence.

The People's Ecosystem was founded in the heart of the social equity cannabis movement — built by and for Black and brown communities who were most harmed by prohibition.

Today, we carry that same commitment into the next frontier: plant therapeutics research. We develop standardized, clinical-grade plant-derived products to be tested in formal medical trials — creating the evidence base that communities of color have long been denied.

Plant medicine is not alternative. It is ancestral. And it deserves the rigor of science to become accessible to all.

01

Clinical-Grade Formulations

Standardized plant medicine products engineered to meet the exacting protocols of medical clinical trials.

02

Evidence-Based Research

Bridging traditional plant knowledge with peer-reviewed, reproducible science — generating data that matters.

03

Community-Centered Access

From patient recruitment to outcomes tracking, we center the communities most likely to benefit.

04

Rooted in Equity

Every trial partnership and research protocol reflects our founding commitment to social equity and justice.

Plant medicine,
rigorously
studied.

Our therapeutic pipeline focuses on naturally occurring compounds with promising evidence for inflammation, neurological health, and chronic illness — conditions that disproportionately impact communities of color.

01
Cannabinoid Therapeutics

Standardized cannabinoid formulations for clinical evaluation across autoimmune, inflammatory, and pain conditions including Lupus, MS, and chronic pain.

02
Psilocybin-Assisted Protocols

Evidence-informed psilocybin formulations for trials exploring mental health, treatment-resistant depression, PTSD, and end-of-life distress.

03
Adaptogenic Compounds

Plant-derived adaptogens under investigation for stress-mediated disease, immune modulation, and cardiovascular wellness.

04
Trial Product Development

GMP-compliant trial materials with consistent dosing, verified purity, and audit-ready documentation for research partners.

05
GPCore Data Registry

Our patient data registry captures longitudinal outcomes to build the evidence base for plant therapeutics at scale.

06
Research Partnerships

Collaborating with research institutions, clinical sites, and pharma partners to design and execute rigorous trials from Phase I onward.

This research
needs you.

Whether you are a patient seeking access to plant medicine trials, a clinician, or a research organization — there is a place for you in this work. Plant therapeutics has historically excluded the communities who stand to benefit most. We are changing that.

For Patients

Join a Clinical Trial

If you are living with a chronic condition — including autoimmune disease, chronic pain, depression, or PTSD — you may be eligible for one of our upcoming trials.

Express Interest
For Caregivers

Support a Loved One

Caregivers and advocates play a vital role in connecting patients to emerging plant therapeutics research. Learn how to support participation.

Learn More
Just another WordPress site
"Born from the community.
Proven for the community."
Just another WordPress site

Built from
lived
experience.

The People's Ecosystem was born out of the social equity cannabis movement in Oakland, California — a company founded by and for communities of color, rooted in advocacy for the formerly incarcerated and the belief that plant medicine should be accessible to those who need it most.

Our founder, Christine De La Rosa, has lived the intersection of chronic illness and plant medicine firsthand. Managing Lupus for decades — and having faced life-threatening complications including a COVID-related cardiac event in 2024 — she has experienced the profound gap between conventional medicine and the healing that plant therapies can offer.

That gap is what we are here to close. Not with anecdote, but with science. Not for some communities, but for all of them.

As we evolve from cannabis retail into clinical therapeutics, we carry forward every hard-won lesson: that the people most harmed by medical exclusion are also the people most poised to benefit from plant medicine's promise.

Let's build
this together.

Whether you are a patient, a clinician, a research institution, or a funding partner — we want to hear from you.

We are currently establishing partnerships for our inaugural clinical trial cohort and recruiting patients for upcoming studies.